See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2022_Mersana_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 188,898,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,968,000 |
| 3 | remainder_Assets | 15,245,000 |
| 4 | LiabilitiesCurrent | 47,523,000 |
| 5 | LiabilitiesNoncurrent | 36,847,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 83,558,551 |
| 9 | ResearchAndDevelopmentExpense | 196,078,544 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 325,002 |
| 12 | remainder_NetIncome | -2,023,491 |
| 13 | remainder_ComprehensiveNetIncome | -9,695 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 206,111,000 |
| 1 | Liabilities | 84,370,000 |
| 2 | Expenses | 279,637,095 |
| 3 | Revenues | 325,002 |
| 4 | StockholdersEquity | 121,741,000 |
| 5 | NetIncome | -281,335,584 |
| 6 | ComprehensiveNetIncome | -281,340,432 |
| 7 | BaseVar | 286,238,142 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.110 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
